Opinion: Purple Book Patent Listings Are Only a First Step
May 8, 2021
By: Ted Mathias and Aaron Savit, PhD
The Center for Biosimilars
Axinn partners Ted Mathias and associate Aaron Savit authored The Center for Biosimilars article, "Opinion: Purple Book Patent Listings Are Only a First Step."
Click here to access the article.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Informa Antitrust Texas 2025
Speaking Engagement
Antitrust
ACI Forum on Pharma & Biotech Patent Litigation USA 2025
Speaking Engagement
Intellectual Property
MCCA Gala 2025
Sponsorship
Antitrust
Centerforce IP Strategy Summit: Palo Alto
Speaking Engagement
Intellectual Property
Consero Healthcare General Counsel Forum 2025
Speaking Engagement
Antitrust
CCWC 21st Annual Career Strategies Conference
Speaking Engagement
Pro Bono Partnership 28th Anniversary Gala
Sponsorship
Antitrust
Ronald McDonald House New York Together in Gold Annual Gala
Sponsorship
Antitrust
Fordham 52nd Annual Conference on International Antitrust Law and Policy
Speaking Engagement
Antitrust
Kisaco Research Trade Secret Legal Protection Conference 2025
Speaking Engagement
Intellectual Property